Molecular characterization of congenital myasthenic syndromes in Spain
- PMID: 29054425
- DOI: 10.1016/j.nmd.2017.08.003
Molecular characterization of congenital myasthenic syndromes in Spain
Abstract
Congenital myasthenic syndromes (CMS) are a heterogeneous group of genetic disorders, all of which impair neuromuscular transmission. Epidemiological data and frequencies of gene mutations are scarce in the literature. Here we describe the molecular genetic and clinical findings of sixty-four genetically confirmed CMS patients from Spain. Thirty-six mutations in the CHRNE, RAPSN, COLQ, GFPT1, DOK7, CHRNG, GMPPB, CHAT, CHRNA1, and CHRNB1 genes were identified in our patients, with five of them not reported so far. These data provide an overview on the relative frequencies of the different CMS subtypes in a large Spanish population. CHRNE mutations are the most common cause of CMS in Spain, accounting for 27% of the total. The second most common are RAPSN mutations. We found a higher rate of GFPT1 mutations in comparison with other populations. Remarkably, several founder mutations made a large contribution to CMS in Spain: RAPSN c.264C > A (p.Asn88Lys), CHRNE c.130insG (Glu44Glyfs*3), CHRNE c.1353insG (p.Asn542Gluf*4), DOK7 c.1124_1127dup (p.Ala378Serfs*30), and particularly frequent in Spain in comparison with other populations, COLQ c.1289A > C (p.Tyr430Ser). Furthermore, we describe phenotypes and distinguishing clinical signs associated with the various CMS genes which might help to identify specific CMS subtypes to guide diagnosis and management.
Keywords: CHRNE; COLQ; Congenital myasthenic syndrome; DOK7; GFPT1; GMPPB; Genetic mutations; RAPSN; Slow-channel syndrome.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis.Brain. 2024 May 2:awae124. doi: 10.1093/brain/awae124. Online ahead of print. Brain. 2024. PMID: 38696726
-
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.Int J Mol Sci. 2023 Feb 13;24(4):3730. doi: 10.3390/ijms24043730. Int J Mol Sci. 2023. PMID: 36835142 Free PMC article. Review.
-
Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.Neuromuscul Disord. 2017 Feb;27(2):136-140. doi: 10.1016/j.nmd.2016.11.014. Epub 2016 Nov 24. Neuromuscul Disord. 2017. PMID: 28024842 Free PMC article.
-
[Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S45-55. doi: 10.1016/S0035-3787(13)70060-2. Rev Neurol (Paris). 2013. PMID: 23452772 Review. French.
-
Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):973-7. doi: 10.1136/jnnp.2009.177816. Epub 2010 Jun 20. J Neurol Neurosurg Psychiatry. 2010. PMID: 20562457
Cited by
-
Innovative Therapeutic Approaches in Congenital Myasthenic Syndromes.Neurol Clin Pract. 2024 Jun;14(3):e200277. doi: 10.1212/CPJ.0000000000200277. Epub 2024 May 7. Neurol Clin Pract. 2024. PMID: 38737513
-
Congenital myasthenia syndrome with demyelinating sensorimotor neuropathy responsive to salbutamol monotherapy: a novel clinical phenotype of CHRNE mutation.Neurol Sci. 2024 Jul;45(7):3555-3558. doi: 10.1007/s10072-024-07420-z. Epub 2024 Feb 27. Neurol Sci. 2024. PMID: 38411853 No abstract available.
-
Mild phenotype of CHAT-associated congenital myasthenic syndrome: case series.Front Pediatr. 2024 Jan 18;12:1280394. doi: 10.3389/fped.2024.1280394. eCollection 2024. Front Pediatr. 2024. PMID: 38304750 Free PMC article.
-
Agenesis of Pectoralis Major Muscle in Late-Onset GFPT1-Related Congenital Myasthenic Syndrome: A Case Report.Neurol Genet. 2023 Sep 26;9(6):e200102. doi: 10.1212/NXG.0000000000200102. eCollection 2023 Dec. Neurol Genet. 2023. PMID: 38235042 Free PMC article.
-
Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre.Brain Commun. 2023 Nov 9;5(6):fcad299. doi: 10.1093/braincomms/fcad299. eCollection 2023. Brain Commun. 2023. PMID: 38035366 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous